FORTUNE -- It has no been more than 2½ years since President Obama signed the Volcker Rule into law, as part of the broader Dodd-Frank financial reform package. And in that time Wall Street bankers have learned a very important lesson: Don't be too quick to honor Washington's wishes.
The Volcker Rule was intended to prevent banks from taking too many risks with their own money, including in areas like private equity and hedge fund investing. The idea was that banks primarily exist to serve clients rather than to enrich themselves via levels of proprietary and principal account investing that could (theoretically) lead to another Lehman-style collapse.
MORE: Goldman employees no longer wealthy?
It was controversial on Wall Street, but so was virtually every single word of Dodd-Frank. Outside the financial lobby's echo chamber, most of the Volcker Rule seemed to be a reasonable safeguard. So it passed through Congress, albeit a bit watered down, in July 2010. Included was a two-year waiting period that would allow politicians and regulators to hammer out the final language.
Many institutions soon began trying to get their houses in order, with efforts to sell or spin out private equity groups. These moves happened at banks in the U.S. and abroad, including Bank of America (BAC), Barclays (BCS), and Lloyds (LYG). Better to comply early than be stranded by unforeseen circumstances, even if that meant divesting at a discount.
Politicians and regulators, however, have not seen fit to reward such prudence. Instead, they've tacitly penalized it by missing so many deadlines that we still don't have any final Volcker Rule language -- a full seven months after the law was supposed to take effect. Even if the procrastinating "authors" were to fulfill their obligations tomorrow, the Volcker Rule might not have any actual teeth until 2014. And, even then, it is expected to include so many exemptions and extensions that banks could be allowed to maintain existing private equity investments for upwards of a decade.
MORE: Volcker specter haunts private equity
The Volcker Rule: safeguarding us from financial crises in 2024 and beyond. Catchy tag line. Wonder why President Obama didn't hand it out on bumper stickers during the 2010 signing ceremony.
The smart money either ignored Volcker on private equity or applied it only to future activities. The most obvious example is Goldman Sachs (GS), which in 2007 raised a $20.3 billion private equity fund called GS Capital Partners VI that included approximately $9 billion in commitments from the bank and bank employees (too high a percentage to comply with Volcker). Goldman has decided not to divest its interest in the fund, believing that it will be able to secure enough extensions to responsibly liquidate once Volcker is finalized. The bank's group also has raised several new funds since Dodd-Frank was signed, including an energy fund, a renminbi-denominated fund, and a real estate mezzanine fund. Goldman believes these new vehicles will comply with Volcker, based on language in a draft proposal of the rule. But if not, it can either request extensions or spin them out to a later date.
MORE: Lloyd Blankfein - bond bubble is looming
In other words, Goldman Sachs is profiting from activities that may be banned under Volcker because it didn't begin moving when Obama's pen struck paper. In fact, its earnings are probably amplified because rising public equity values over the past two years have led to a particularly strong exit environment for private equity. And the exact opposite is true for banks and other regulated institutions that divested from private equity during the past three years, based on the false assumption that Congress actually meant what it passed.
So the Volcker Rule has become a cautionary tale, but for all the wrong reasons. It was intended to help curb Wall Street recklessness -- a culture in which banks invest first and ask questions later. But instead it just validated those who expertly exploit the sloth of federal officials and encouraged such behavior the next time around. Some reform.
This story is from the February 4, 2013 issue of Fortune.
One of private equity's biggest sources of investing income may soon dry up. Their loss could be your gain.
FORTUNE -- Private equity isn't all that private. More than 25% of the industry's money actually comes from U.S. public pension systems, which represent everything from firefighters to teachers to subway workers. From 2001 to 2010, that worked out to approximately $385 billion for domestic private equity coffers. This cannot last forever. MORE
Dan Primack - Dec 20, 2012 5:00 AM ET
The botched offering is sure to make other successful startups think twice before putting themselves at the mercy of the common markets.
FORTUNE --There are lots of lessons to be drawn from the Facebook IPO: Don't let your CFO scrounge for every last dime. Make sure your CEO pays wardrobe deference to Wall Street. Remove board members who are more loyal to their bank accounts than to the company. But those MORE
Dan Primack - Sep 21, 2012 5:00 AM ET
A little mud slinging is inevitable in a heated race such as this year's. But out-and-out lies? Let's set the record straight.
FORTUNE – Last summer I wrote in this space that Mitt Romney's political ambitions would hurt private equity. What I didn't realize at the time was that private equity would also hurt politics.
We have come to expect a certain amount of half-truths and message spinning in our electoral discourse. MORE
Dan Primack - Aug 21, 2012 5:00 AM ET
Schilling, 400 employees, and Rhode Island taxpayers had to learn the hard way that venture capital is best left to those who know how to make money.
FORTUNE -- Five years ago Curt Schilling was a hero in New England, right up there with Paul Revere, J.F.K., and the mustachioed Dunkin' Donuts man. Today the former Red Sox pitcher is a pariah after his videogame company went bust, taking hundreds of MORE
Dan Primack - Jun 15, 2012 5:00 AM ET
Investors are ignoring a key source of income, and that means shares aren't getting the respect they deserve.
FORTUNE -- Shortly after the Blackstone Group went public in mid-2007, I advised friends not to buy the stock. Investors didn't seem to understand how private equity firms like Blackstone should be valued, as illustrated by a 6% share price bump in the days after Blackstone agreed to acquire Hilton Hotels. Private equity MORE
Dan Primack - May 3, 2012 5:00 AM ET
It's easy to point the finger at a Democratic president who wants to reform the corporate tax code, but the real enemy is a lot closer to home.
FORTUNE -- Many private equity investors are convinced that President Obama is their enemy, not only because he wants to defeat former Bain Capital boss Mitt Romney in November, but also because of a new corporate tax reform proposal that could make private MORE
Dan Primack - Mar 28, 2012 5:00 AM ET
The GOP front-runner appears to have forgotten almost all the lessons he learned at Bain Capital.
FORTUNE -- Mitt Romney is straight out of GOP central casting for presidential candidates: a tall, confident family man whose greatest professional accomplishments were in the private sector rather than in government. Too bad he keeps flubbing his lines.
Romney comes from the world of private equity, where investors are expected to develop investment theses -- MORE
Dan Primack - Feb 13, 2012 5:00 AM ET
A new bill aims to make it easier for more companies to go public. But what if they don't need to?
FORTUNE -- Congress has proved itself incapable of finding bipartisan solutions to our nation's most acute problems. But when it comes to imaginary crises, it's doing a bang-up job.
Last month Senators Chuck Schumer (D-N.Y.) and Pat Toomey (R-Pa.) introduced new legislation called the Reopening American Capital Markets to Emerging Growth MORE
Dan Primack - Jan 5, 2012 5:00 AM ET
Big drugmakers are submitting to investors' short-sightedness instead of doing the right thing.
FORTUNE -- Earlier this year, drug giant Pfizer (PFE) announced plans to slash spending on research and development by a third. Its shares closed that day up more than 5%. Two days later rival Merck (MRK) went the other way, saying it would maintain existing R&D levels. Its shares fell by nearly 3%. Investors had sent Big Pharma MORE
Dan Primack - Nov 28, 2011 5:00 AM ET| The Winklevoss twins are Bitcoin bulls | ||
| Bernanke's advice for college grads | ||
| Signs of new housing bubble in several areas | ||
| Prison exclusive: Bernie Madoff can't sleep | ||
| Dirty medicine |